Stockreport

Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results [Yahoo! Finance]

Theriva Biologics, Inc.  (TOVX) 
PDF the VIRAGE Phase 2b trial presented at the European Society for Medical Oncology (ESMO) Annual Congress 2025 - - Next generation oncolytic virus VCN-12 preclinical dat [Read more]